中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2013年
30期
7-8,11
,共3页
刘小林%吴国伟%刘才英%张程赪
劉小林%吳國偉%劉纔英%張程赪
류소림%오국위%류재영%장정정
双相情感障碍%生活质量%治疗成本
雙相情感障礙%生活質量%治療成本
쌍상정감장애%생활질량%치료성본
Bipoiar disorder%Quality of Life%Remedy Cost
目的:通过比较首发和复发双相情感障碍患者生活质量和治疗成本,为早期干预提供依据。方法对50例首发和50例复发双相情感障碍患者在入组后第3、6、9、12个月进行生活质量、疾病治疗的直接成本及间接成本的随访。以贝克-拉范森躁狂量表(BRMS-11)汉密尔顿抑郁量表17项(HAMD-17)和健康状况调查问卷(SF-36)分别评定患者疗效,随访12个月进行两组的生活质量与经济成本比较。结果①首发组SF-36躯体功能和躯体疼痛情况好于复发组(P<0.05),其他因子两组无明显差异(P>0.05);②复发组的总成本绝对值、间接成本绝对值及间接成本所占比例均高于首发组(P<0.01)。结论双相情感障碍的复发患者与首发患者相比,生活质量和治疗花费成本更多。
目的:通過比較首髮和複髮雙相情感障礙患者生活質量和治療成本,為早期榦預提供依據。方法對50例首髮和50例複髮雙相情感障礙患者在入組後第3、6、9、12箇月進行生活質量、疾病治療的直接成本及間接成本的隨訪。以貝剋-拉範森躁狂量錶(BRMS-11)漢密爾頓抑鬱量錶17項(HAMD-17)和健康狀況調查問捲(SF-36)分彆評定患者療效,隨訪12箇月進行兩組的生活質量與經濟成本比較。結果①首髮組SF-36軀體功能和軀體疼痛情況好于複髮組(P<0.05),其他因子兩組無明顯差異(P>0.05);②複髮組的總成本絕對值、間接成本絕對值及間接成本所佔比例均高于首髮組(P<0.01)。結論雙相情感障礙的複髮患者與首髮患者相比,生活質量和治療花費成本更多。
목적:통과비교수발화복발쌍상정감장애환자생활질량화치료성본,위조기간예제공의거。방법대50례수발화50례복발쌍상정감장애환자재입조후제3、6、9、12개월진행생활질량、질병치료적직접성본급간접성본적수방。이패극-랍범삼조광량표(BRMS-11)한밀이돈억욱량표17항(HAMD-17)화건강상황조사문권(SF-36)분별평정환자료효,수방12개월진행량조적생활질량여경제성본비교。결과①수발조SF-36구체공능화구체동통정황호우복발조(P<0.05),기타인자량조무명현차이(P>0.05);②복발조적총성본절대치、간접성본절대치급간접성본소점비례균고우수발조(P<0.01)。결론쌍상정감장애적복발환자여수발환자상비,생활질량화치료화비성본경다。
Objective To compare life quality and health costs in ifrst-episode and recurrent outpatients with bipoiar disorder, thus providing evidence for early intervention. Methods 50 ifrst-episode and 50 recurrent outpatients with bipoiar disorder were recruited and life quality, direct and indirect health related costs were evaluated at the 3rd, 6th, 9th and 12th month. The clinical status and life quality of patients were assessed using Bech-Rafaelsdn Mania Rating Scale(BRMS-1),Hamilton depression scale-17 items (HAMD-17) and the Short-form-36 than health survey(SF-36). Result ①First-episode patients had better physical function and less physical pain in SF-36 than recurrent ones (P<0.05),while no difference were found for other SF-36 factors(P>0.05).②Total costs, indirect health-related costs, and proportion of indirect costs but not direct costs were higher in the recurrent group than in the ifrst-episode group(P<0.01).Costs of effectiveness ratios were much higher in the recurrent group than that in the ifrst-episode group in terms of costs of unit decrease in HAMD-17 or unit increase in SF-36. Conclusions Patients with recurrent bipoiar disorder intend to have more severe impairment of quality of life, less productivity and higher health costs.